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ELISA, and then genotypes and subgenotypes was identiﬁed on
four modes by using genotype-speciﬁc-primer PCR and nested
polymerase chain reaction-restriction fragment length polymor-
phism (nested PCR-RFLP) and 5 cases of identiﬁed genotypes
were randomly selected for directly sequencing their S gene to
verify the accuracy of genotype-speciﬁc-primer PCR.
Result: 1. 57 samples were tested for the positive of HBV
genotype,of which exist 34 genotype B,12 genotype C and 11
genotype B+C mixed, Genotype B is more prevalent in our group;
There were 37 HBV subgenotype positive in identiﬁed genotype
samples, of which exist 24 subgenotype Ba, 12 subgenotype Cs
and 1 subgenotype Ce, Ba was main subgenotype in the group. 2.
The HBV infection factors such as age,gender and marital status
was not statistically signifycant except nation (p=0.0001).
Conclusion: The Result show: 1. Genotype B and subgenotype
Ba were the predominant strains in the minority groups of Yun-
nan province. 2. Nation and the positive rate of HBsAg showed
correlatitive, but age, gender and marital status existed no
difference.
PP-076 Diagnostic values of transforming growth factor
(TGF)-β1 and TGF-β1 mRNA in HBV-related
hepatocellular carcinoma
Zhizhen Dong*,1, Dengfu Yao2, Liwei Qiu2, Shanshan Li 2,
Yinzhu Bian2. 1Department of Diagnostics, 2Research Center of
Clinical Medicine, Afﬁliated Hospital of Nantong University,
Nantong, China
Background: To investigated the characteristics of TGF-β1 and
TGF-β1-mRNA expression, their relationship with HBV replica-
tion, and their diagnostic values for HCC.
Methods: Total RNAs were extracted from HCC tissues and their
matched non-tumor tissues, or from PBMCs in HCC patients. TGF-
β1 mRNA were ampliﬁed by RT-PCR and conﬁrmed by sequencing.
TGF-β1 expression was examined by immunohistochemistry. The
clinical characteristics were analyzed between TGF-β1 and HBV
replication. Diagnostic values of TGF-β1 and TGF-β1 mRNA were
investigated.
Results: The incidence of TGF-β1 expression was 83.3% in HCC,
43.3% in their surrounding tissues, 94.7% in HBV-DNA-positive
group, and 63.6% in HBV-DNA-negative one, respectively. TGF-β1
expression were associated with the degree of HCC differentia-
tion and the statue of HBV replication, but neither to size nor to
number of tumors. Circulating TGF-β1 level or incidence of TGF-
β1 mRNA was signiﬁcantly higher in HCC group than any group of
patients with benign liver diseases, with higher sensitivity (89.5%)
and speciﬁcity (94.0%) for HCC diagnosis when TGF-β1 level (>
1.2 μg/L). No signiﬁcant correlation was found between TGF-β1
expression and AFP levels or tumor sizes. Combined TGF-β1 level
and serum AFP could raise the detection rate up to 97.4%.
Conclusion: The abnormal expression of TGF-β1 was associated
with degree of HCC differentiation and HBV replication. Both of
TGF-β1 and TGF-β1-mRNA could be used as sensitive biomarkers
for diagnosis and prognosis of HBV-related HCC.
PP-077 Variation and signiﬁcance of CD4+CD25+
regulatory T cells in chronic hepatitis B patients
who complicated with hepatic steatosis
Caiyan Zhao*,1, Pingping Zhang1, Meng Zhao2, Jianhua Lu3,
Yadong Wang1, Junying Zhou1, Zhen Zhen1. 1Department of
Infectious Disease, Third Afﬁliated Hospital of Hebei Medical
University, Shijiazhuang, China; 2Department of Central
Laboratory, Third Afﬁliated Hospital of Hebei Medical
University, Shijiazhuang, China; 3Department of Laboratory,
The Fifth Hospital of Shijiazhuang,China
Background: Hepatic steatosis is common in chronic hepatitis B
(CHB) patients. The aim of this study was to investigate the effect
and signiﬁcance of hepatic steatosis to CD4+CD25+ regulatory T
cells (Tregs) in CHB patients.
Methods: Tregs in peripheral blood and expression of Foxp3 in
liver tissue were examined by ﬂow cytometry and immunohisto-
chemistry respectively. HBV markers, alanine aminotransferase
(ALT) and HBV DNA levels were measured in each subject.
Results: ALT, HBV DNA and the inﬂammatory grade (G) of liver
tissue in patients who had CHB plus hepatic steatosis were similar
to CHB group; The percentage of Tregs in peripheral blood of pa-
tients with CHB plus hepatic steatosis was lower than that in CHB
patients but higher than control group, which was coincided with
the change of Foxp3 positive Tregs in liver tissue; The percentage
of Tregs in high ALT group was higher compared with low ALT
group; The inﬂammatory grade of liver tissue in 14 patients was
G2, in other 16 patients was G3, Foxp3 positive Tregs in the latter
group were more than those in the former group; The percentage
of Tregs was not associated with HBV DNA level.
Conclusion: Tregs in peripheral blood and liver tissue of patients
with CHB plus hepatic steatosis are fewer compared with CHB
patiens, and Tregs have a close relation with hepatic inﬂam-
mation. The decreased Tregs may lead to a lower suppression
of inﬂammatory response, further more, the progression of CHB
would be accelerated.
PP-078 Effect of PDTC on NF-κB in the inﬂammatory
injury and inducible nitric oxide in experimental
fulminant hepatic failure
Zhen Zhen, Xiaojuan Ren*, Qian Liu. Department of Infectious
Disease, Third Afﬁliated Hospital, Hebei Medical University
Objective: to investigate the signiﬁcance of the inhibition of NF-
κB in D-galactosamine + Lipopolysaccharide-induced fulminant
hepatic failure.
Methods: 60 Wistar rat were divided randomly to model group
and PDTC group, which has 30 rats respectively. The serum
and liver tissue were maintained. Hepatic tissue was observed
by Routine HE staining; The levels of serum ALT and TB were
detected by automatic biochemical analyzer. The changes of
serum NO were detected by using nitrate reductase assay. The
expression of NF-κB and iNOS mRNA were detected by RT-PCR.
Results: 1. The inﬂammation and necrosis were reduced in PDTC
group. 2. Except for 8 hour, the ALT levels were lower than that
of the model group (P<0.05). The TB level were lower than the
model group at 4, 12, 24 hour, and the difference had statistical
signiﬁcance (P<0.05). NO of the serum in model group were
lower than that of model group at 2, 8, 12 hour, and the differ-
ence had statistical signiﬁcance (P<0.05). 3. At 4, 8 hour, the
expression of NF-κB mRNA in PDTC group was lower than model
group at corresponding different time. And the difference had
statistical signiﬁcance (P<0.05). At 4 and 8 hour, the expression
of iNOS mRNA in PDTC group was lower than that of model group
at corresponding different time (P<0.05).
Conclusion: NF-κB plays an important role in the hepatic inﬂam-
mation of D-GalN+LPS-induced fulminant hepatic failure. PDTC
can attenuate hepatic inﬂammation and necrosis through the
inhibition of NF-κB.
PP-079 Risk factors for the prognosis in chronic hepatic
failure and construction of the prognostic model
Junxue Wang*,1, Chao Lu1, Wu Ni1, Jian Liu2, Haiguang Xin1,
Xiong Cai 1. 1Department of Infectious Disease, Changzheng
Hospital, ShangHai; 2Department of Statics, the Second Military
Medical University, Shanghai, China
Background: To investigate the correlation between the risk fac-
tors and prognosis of chronic hepatic failure and try to construct
the prognostic model.
Methods: All 28 patients with chronic hepatic failure were di-
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vided into improved group and exacerbation group. The following
clinical data and laboratory examinations were studied: ascites,
spontaneous bacterial peritonitis (SBP), alimentary tract hem-
orrhage, hepatocerebral disease, hepatorenal syndrome (HRS),
prothrombin time (PT), prothrombin time activity (PTA), Inter-
national ratio (INR), blood coagulation factor V (FV:C), ﬁbrino-
gen (FIB), D-dimer (D-D), total cholesterol (TC), total bilirubin
(TBIL), albumin (ALB), prealbumin (PRE-A), alanine aminotrans-
ferase (ALT), Blood urea (BUN), serum creatinine (SCR), blood
platelet (PLT). Analyze the index above with SPSS computer
software (SPSS version 12.0) by logistic regression for univariat
and multivariant analysis.
Results: Using logistic regression analysis, we found that: 1.
Ascites, SBP, hepatocerebral disease, PT, PTA, INR, FV:C, D-D,
TC, TBIL, PRE-A were signiﬁcantly different between the two
groups (P<0.05) in the univariat analysis; 2. TC, FV:C and ascites
were signiﬁcant risk factors for the prognosis of chronic hepatic
failure (P<0.05) in the multivariant analysis
Conclusion: TC, FV:C and ascites are valuable in predicting pa-
tients with chronic hepatic failure. A prognostic model: Y = 1/[1
+ exp(–s)], s = 191.13 – 34.81∗FV:C – 34.68∗TC – 35.22∗ascites
(Y means the possibility of patient’s death), was constructed by
logistic regression analysis.
PP-080 Application of CD3 gating to dection of HBV
MHC-pentamer
Yanping Han1,2, Jun Li *,1,2, Bo Liu1,2, Yufeng Wan3, Ke Jin1,2,
Yang Cao1,2, Yuan Liu1,2, Zuhu Huang1,2. 1Department of
Infectious Diseases; 2The First Afﬁliated Hospital with Nanjing
Medical University; 3The Second People Hospital of Huaian
Objectives: To observe differences in speciﬁcity and stability of
speciﬁc cytotoxic T cells (CTL), and select the best experimental
conditions suitable for detection of HBV-speciﬁc CTL.
Methods: After HLA-A0201 and HLA-2402 allele-positive HBV-
infected persons were screened by high-resolution SSP-PCR;
PBMC of them were stained by different PE-labelled HBcAg epi-
tope peptide complex, PerCP Cy5.5-labelled mouse anti-human
CD3 monoclonal antibody and APC-labelled mouse anti-human
CD8 monoclonal antibody respectively. Except for T lympho-
cytes, other cells which may be combined with Pentamer were
removed by CD3 gating, comparing different kinds of added order
of three reagents and by the multi-parameter ﬂow cytometry
analysis.
Results: Frequencies of epitope-speciﬁc CTL from HBV-infected
persons who did not match HLA alleles were signiﬁcantly lower
than those of matched HLA alleles, P<0.05; Using the method
that MHC-Pentamer and test samples were coincubated for 20min
before adding CD3-PerCP Cy5.5 and CD8-APC which were coincu-
bated 20min later, frequencies of HBV-speciﬁc CTL were higher
than that of other groups, P<0.05; Frequencies of HBV-speciﬁc
CTL from CHB were signiﬁcantly lower than that of AHB, P<0.05.
Conclusion: If CTL epitopes and HLA alleles were matched, ratio
of speciﬁc CTL can be improved; Both CD3 monoclonal anti-
body and CD8 monoclonal antibody can prevent MHC-Pentamer
from combinating with the TCR, thereby frequencies of speciﬁc
CTL were reduced; Inadequate speciﬁc CTL of CHB may be one
important reasons for chronic infection.
PP-081 Analysis of inﬂuential factors of prognosis of
patients with acute-on-chronic hepatitis B liver
failure after lamivudine treatment
Li-jie Sun*, Jian-wu Yu, Yong-hua Zhao, Shu-chen Li,
Shu-chen Li. Department of Infectious Diseases, Second
Afﬁliated Hospital, Harbin Medical University
To evaluate the efﬁcacy of lamivudine treatment in patients with
acute-on-chronic liver failure (ACLF) and study the impact of HBV
DNA load and its related factors on the prognosis of patients with
acute-on-chronic liver failure (ACLF) after lamivudine treatment.
Methods: One hundred and thirty ACLF patients were treated
with lamivudine and the inﬂuential factors on mortality of pa-
tients were studied by univariate and multivariate analysis.
Results: The mortality (50.0%) of patients in lamivudine group
with MELD score from 30 to 40 was lower than that (86.1%) of
control group (χ2=23.319, P=0.000). The mortality of patients
with high virus load group (72/100, 72.0%) was higher than that
of low virus load group (15/30, 50.0%) (χ2=5.046, P=0.025). For
patients with MELD score from 30 to 40, by week 4 the mortality
of patients with HBV DNA undetectable or more than 2 log10
decline (2/13, 15.4%; 18/40, 45.0%) was lower than that of pa-
tients with less than 2 log10 decline (18/23, 78.3%) (χ2=15.328,
P=0.002). In multivariate analysis, in patients with MELD scores
30-40, treatment method (P=0.004), pretreatment HBV DNA load
(P=0.009), decline of HBV DNA load during therapy (P=0.014)
and encephalopathy (P=0.019) were independent predictors of
mortality; for MELD scores above 40, only MELD score (P=0.015)
was independent predictive.
Conclusions: Lamivudine treatment signiﬁcantly decreases the
3-month mortality of patients with MELD score 30-40, and a low
viral load pre-treatment and quick decline of HBV DNA load are
good predictors for the survival of lamivudine treatment.
PP-082 A Cis-acting regulatory variation of estrogen
receptor-α and the association with HBV-related
liver diseases
Zehui Yan*, Guohong Deng, Wenting Tan, Wenli Zhao, Yunjie Dan,
Wen Chen, Yingzi Tang, Xia Zhou, Xiaohong Wang, Qing Mao,
Yuming Wang. Department of Infectious Diseases, Southwest
Hospital, Third Military Medical University, Chongqing, China
Background & Aims: We have reported that the genetic varia-
tion at the ESR1 locus inﬂuences susceptibility to persistent HBV
infection and HBV-related liver disease. However, further studies
are needed to determine whether the polymorphism (IVS1-401)
located in intron 1 is a regulatory polymorphism and clarify
its functional molecular mechanisms for this association with
chronic HBV infection and HBV-related diseases.
Methods: In a hospital-based case-control cohort composed of
359 HBV-related acute liver failure patients, 464 HBV-related
liver cirrhosis patients and 469 HBV asymptomatic carriers,
three polymorphisms (IVS1 T-401C, T29C, A11940G) of ESR1 gene
were analyzed using the polymerase chain reaction-restriction
fragment length polymorphism assay. Functional analyses were
conducted to verify the biological signiﬁcances of the associated
genetic variation.
Results:We found that the polymorphisms, T-401C and T29C, was
associated with susceptibility to HBV-ALF (dominant model; odds
ratio, 1.73; P=0.000) and HBV-LC (dominant model; odds ratio,
2.07; P=0.000). Functional analyses show that IVS1 T-401C poly-
morphism alters the binding afﬁnity of c-Myb and regulates ESR1
expression. The disease-susceptible allele, -401C, has stronger
ability to regulates ESR1 expression.
Conclusions: ESR1 IVS1 T-401C polymorphism is a cis-regultory
variant and -401C allele contributes to the risk of occurrence
of HBV-related liver failure and cirrhosis by binding c-Myb and
altering ESR1 exression
